Clinical Trial

Melatonin and Osteogenic Loading on Osteopenia

Study acronym: MelaOstrong
Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study will be assessing the efficacy of melatonin and/or osteogenic loading on modulating bone health in an osteopenic population.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2020-01-15; most recent amendment 2025-08-18.
Status change: Recruiting → Active, Not Recruiting 2023-06-22
Status change: Not Yet Recruiting → Recruiting 2020-05-27
Trial Details
NCT Number NCT04233112
Lead Sponsor Duquesne University
Collaborators: OsteoStrong
Conditions Osteopenia
Enrollment 40 participants
Start Date 2020-05-26
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-22